prednisone has been researched along with Colorectal Cancer in 17 studies
Prednisone: A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver.
prednisone : A synthetic glucocorticoid drug that is particularly effective as an immunosuppressant, and affects virtually all of the immune system. Prednisone is a prodrug that is converted by the liver into prednisolone (a beta-hydroxy group instead of the oxo group at position 11), which is the active drug and also a steroid.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A 52-year-old woman was treated for colorectal diffuse large B-cell lymphoma (DLBCL) after a prolonged treatment period of azathioprine (AZA) and infliximab (IFX) for Crohn's disease (CD)." | 7.96 | Diffuse large B-cell lymphoma of the colon and rectum in a patient with colonic Crohn's disease treated with infliximab and azathioprine. ( Daikuhara, S; Hirayama, A; Sato, K; Suga, T; Tanaka, E; Uehara, T, 2020) |
| "Colorectal cancer surveillance should be considered for HL survivors who received Infradiaphragmatic radiotherapy and a high cumulative procarbazine dose." | 7.85 | Infradiaphragmatic irradiation and high procarbazine doses increase colorectal cancer risk in Hodgkin lymphoma survivors. ( Aleman, BM; de Boer, JP; De Bruin, ML; Janus, CP; Kremer, LC; Krol, AD; Louwman, MW; Schaapveld, M; van der Maazen, RW; van Eggermond, AM; van Leerdam, ME; van Leeuwen, FE; Visser, O; Zijlstra, JM, 2017) |
| "Regorafenib has been proven to be an effective and well-tolerated therapeutic option in patients with mCRPC progressing after docetaxel plus prednisone treatment." | 5.46 | Efficacy and Safety of the Oral Multikinase Regorafenib in Metastatic Colorectal Cancer. ( Cicero, G; De Luca, R; Dieli, F, 2017) |
| "We reviewed published studies reporting phase II and III clinical trials of dose-dense regimens for breast cancer and NHL, TAC (docetaxel, adriamycin, cyclophosphamide) chemotherapy for breast cancer, and infusional 5-fluorouracil-based regimens for colorectal cancer." | 4.83 | Epidemiology of treatment-associated mucosal injury after treatment with newer regimens for lymphoma, breast, lung, or colorectal cancer. ( Avritscher, EB; Bekele, BN; Cooksley, CD; Elting, LS; Jones, JA; Michelet, M, 2006) |
| "A 52-year-old woman was treated for colorectal diffuse large B-cell lymphoma (DLBCL) after a prolonged treatment period of azathioprine (AZA) and infliximab (IFX) for Crohn's disease (CD)." | 3.96 | Diffuse large B-cell lymphoma of the colon and rectum in a patient with colonic Crohn's disease treated with infliximab and azathioprine. ( Daikuhara, S; Hirayama, A; Sato, K; Suga, T; Tanaka, E; Uehara, T, 2020) |
| "Colorectal cancer surveillance should be considered for HL survivors who received Infradiaphragmatic radiotherapy and a high cumulative procarbazine dose." | 3.85 | Infradiaphragmatic irradiation and high procarbazine doses increase colorectal cancer risk in Hodgkin lymphoma survivors. ( Aleman, BM; de Boer, JP; De Bruin, ML; Janus, CP; Kremer, LC; Krol, AD; Louwman, MW; Schaapveld, M; van der Maazen, RW; van Eggermond, AM; van Leerdam, ME; van Leeuwen, FE; Visser, O; Zijlstra, JM, 2017) |
| "Inflammation is a known pitfall of surveillance colonoscopy for inflammatory bowel disease (IBD) as it is difficult to differentiate between inflammation and true dysplasia." | 2.75 | A short course of corticosteroids prior to surveillance colonoscopy to decrease mucosal inflammation in inflammatory bowel disease patients: results from a randomized controlled trial. ( Baars, JE; Biermann, K; Kuipers, EJ; van der Woude, CJ; Vogelaar, L; Wolfhagen, FH, 2010) |
| "Primary colorectal lymphoma is an infrequent disease of unknown origin and with a growing incidence." | 2.44 | Primary colorectal lymphomas: review of the literature. ( Annoni, M; Bianchi, V; Boni, L; Castano, P; Dionigi, G; Dionigi, R; Rovera, F; Villa, F, 2007) |
| "Regorafenib has been proven to be an effective and well-tolerated therapeutic option in patients with mCRPC progressing after docetaxel plus prednisone treatment." | 1.46 | Efficacy and Safety of the Oral Multikinase Regorafenib in Metastatic Colorectal Cancer. ( Cicero, G; De Luca, R; Dieli, F, 2017) |
| "Periodontitis has been observed infrequently in bevacizumab-containing chemotherapy in clinical practice." | 1.39 | A retrospective analysis of periodontitis during bevacizumab treatment in metastatic colorectal cancer patients. ( Akiyoshi, K; Hamaguchi, T; Hosokawa, A; Iwasa, S; Kato, K; Nakajima, TE; Nishitani, H; Ogawa, K; Shimada, Y; Sugiyama, T; Ueno, T; Yamada, Y, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (41.18) | 29.6817 |
| 2010's | 8 (47.06) | 24.3611 |
| 2020's | 2 (11.76) | 2.80 |
| Authors | Studies |
|---|---|
| Yu, X | 1 |
| Wang, C | 1 |
| Wang, M | 1 |
| Wu, Y | 1 |
| Zhang, L | 1 |
| Yang, Q | 1 |
| Chen, L | 1 |
| van Eggermond, AM | 1 |
| Schaapveld, M | 1 |
| Janus, CP | 1 |
| de Boer, JP | 1 |
| Krol, AD | 1 |
| Zijlstra, JM | 1 |
| van der Maazen, RW | 1 |
| Kremer, LC | 1 |
| van Leerdam, ME | 1 |
| Louwman, MW | 1 |
| Visser, O | 1 |
| De Bruin, ML | 1 |
| Aleman, BM | 1 |
| van Leeuwen, FE | 1 |
| Cicero, G | 1 |
| De Luca, R | 1 |
| Dieli, F | 1 |
| Yue, D | 1 |
| Sun, X | 1 |
| Sato, K | 1 |
| Suga, T | 1 |
| Hirayama, A | 1 |
| Daikuhara, S | 1 |
| Uehara, T | 1 |
| Tanaka, E | 1 |
| Huang, S | 1 |
| Zheng, ZX | 1 |
| Xu, Q | 1 |
| Yuan, XH | 1 |
| Carreres-Prieto, M | 1 |
| López-Sisamón, D | 1 |
| Layos-Romero, L | 1 |
| Zhang, NS | 1 |
| Shi, F | 1 |
| Kong, L | 1 |
| Zhu, H | 1 |
| Baars, JE | 1 |
| Vogelaar, L | 1 |
| Wolfhagen, FH | 1 |
| Biermann, K | 1 |
| Kuipers, EJ | 1 |
| van der Woude, CJ | 1 |
| Ogawa, K | 1 |
| Ueno, T | 1 |
| Kato, K | 1 |
| Nishitani, H | 1 |
| Akiyoshi, K | 1 |
| Iwasa, S | 1 |
| Nakajima, TE | 1 |
| Hamaguchi, T | 1 |
| Yamada, Y | 1 |
| Hosokawa, A | 1 |
| Sugiyama, T | 1 |
| Shimada, Y | 1 |
| Okada, M | 1 |
| Maeda, K | 1 |
| Suzumiya, J | 1 |
| Hagimoto, T | 1 |
| Wakamatsu, S | 1 |
| Ohshima, K | 1 |
| Kanda, M | 1 |
| Sonoda, T | 1 |
| Sakamoto, A | 1 |
| Tamura, K | 1 |
| Pestalozzi, BC | 1 |
| Knuth, A | 1 |
| Jones, JA | 1 |
| Avritscher, EB | 1 |
| Cooksley, CD | 1 |
| Michelet, M | 1 |
| Bekele, BN | 1 |
| Elting, LS | 1 |
| Dionigi, G | 1 |
| Annoni, M | 1 |
| Rovera, F | 1 |
| Boni, L | 1 |
| Villa, F | 1 |
| Castano, P | 1 |
| Bianchi, V | 1 |
| Dionigi, R | 1 |
| Girelli, CM | 1 |
| Serio, G | 1 |
| Rocca, E | 1 |
| Rocca, F | 1 |
| Paira, S | 1 |
| Graf, C | 1 |
| Roverano, S | 1 |
| Rossini, J | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Randomized Study of a New Medical Device for Oral Mucositis (MDOM Trial)[NCT05104268] | Phase 1/Phase 2 | 100 participants (Anticipated) | Interventional | 2021-11-30 | Not yet recruiting | ||
| A Phase 1/Phase 2 Study for the Prevention of Oral Mucositis (SPOM)[NCT05338398] | Phase 1/Phase 2 | 100 participants (Anticipated) | Interventional | 2022-04-15 | Enrolling by invitation | ||
| Phase I Study of Multiple Ascending Dose, to Investigate the Safety and Tolerability of the Use of Copaiba in Patients With Oral Cancer Submitted to Radiotherapy[NCT05308732] | Phase 1 | 36 participants (Anticipated) | Interventional | 2021-05-11 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
4 reviews available for prednisone and Colorectal Cancer
| Article | Year |
|---|---|
[For treatment decision the age to be taken into account. In Crohn's disease and ulcerative colitis attention to be paid to the age at manifestation].
Topics: Adolescent; Adult; Age Factors; Aged; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroi | 2009 |
[New antibodies in cancer treatment].
Topics: Animals; Antibodies, Anti-Idiotypic; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Anti | 2004 |
Epidemiology of treatment-associated mucosal injury after treatment with newer regimens for lymphoma, breast, lung, or colorectal cancer.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms | 2006 |
Epidemiology of treatment-associated mucosal injury after treatment with newer regimens for lymphoma, breast, lung, or colorectal cancer.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms | 2006 |
Epidemiology of treatment-associated mucosal injury after treatment with newer regimens for lymphoma, breast, lung, or colorectal cancer.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms | 2006 |
Epidemiology of treatment-associated mucosal injury after treatment with newer regimens for lymphoma, breast, lung, or colorectal cancer.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms | 2006 |
Epidemiology of treatment-associated mucosal injury after treatment with newer regimens for lymphoma, breast, lung, or colorectal cancer.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms | 2006 |
Epidemiology of treatment-associated mucosal injury after treatment with newer regimens for lymphoma, breast, lung, or colorectal cancer.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms | 2006 |
Epidemiology of treatment-associated mucosal injury after treatment with newer regimens for lymphoma, breast, lung, or colorectal cancer.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms | 2006 |
Epidemiology of treatment-associated mucosal injury after treatment with newer regimens for lymphoma, breast, lung, or colorectal cancer.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms | 2006 |
Epidemiology of treatment-associated mucosal injury after treatment with newer regimens for lymphoma, breast, lung, or colorectal cancer.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms | 2006 |
Primary colorectal lymphomas: review of the literature.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colectomy; Colorectal Neopla | 2007 |
1 trial available for prednisone and Colorectal Cancer
| Article | Year |
|---|---|
A short course of corticosteroids prior to surveillance colonoscopy to decrease mucosal inflammation in inflammatory bowel disease patients: results from a randomized controlled trial.
Topics: Adult; Anti-Inflammatory Agents; Biopsy; Colitis, Ulcerative; Colonoscopy; Colorectal Neoplasms; Cro | 2010 |
12 other studies available for prednisone and Colorectal Cancer
| Article | Year |
|---|---|
Cronkhite-Canada syndrome: a retrospective analysis of four cases at a single medical center.
Topics: Adenoma; Adult; Colorectal Neoplasms; Female; Humans; Intestinal Polyposis; Male; Middle Aged; Polyp | 2022 |
Infradiaphragmatic irradiation and high procarbazine doses increase colorectal cancer risk in Hodgkin lymphoma survivors.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Colon; Colo | 2017 |
Efficacy and Safety of the Oral Multikinase Regorafenib in Metastatic Colorectal Cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocol | 2017 |
Ixazomib promotes CHOP-dependent DR5 induction and apoptosis in colorectal cancer cells.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Boron Compounds; C | 2019 |
Diffuse large B-cell lymphoma of the colon and rectum in a patient with colonic Crohn's disease treated with infliximab and azathioprine.
Topics: Antineoplastic Combined Chemotherapy Protocols; Antirheumatic Agents; Azathioprine; Colorectal Neopl | 2020 |
[Diagnosis and treatment of primary colorectal non-Hodgkin's lymphoma: analysis of 52 cases].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Col | 2013 |
[Interstitial lung disease induced by raltitrexed-oxaliplatin based chemotherapy for colorectal cancer: a case report].
Topics: Aged; Anti-Inflammatory Agents; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms | 2015 |
Mucosa-associated lymphoid tissue lymphoma with unusual
Topics: Adenocarcinoma; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Chemora | 2017 |
A retrospective analysis of periodontitis during bevacizumab treatment in metastatic colorectal cancer patients.
Topics: Adult; Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Beva | 2013 |
Primary colorectal T-cell lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Barium Sulfate; Bleomycin; Colonoscopy; Colorectal N | 2003 |
Refractory ulcerative colitis and iatrogenic colorectal Kaposi's sarcoma.
Topics: Adult; Colectomy; Colitis, Ulcerative; Colon; Colorectal Neoplasms; Cyclosporine; Glucocorticoids; H | 2009 |
Remitting seronegative symmetrical synovitis with pitting oedema: a study of 12 cases.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antineoplastic Agents; Colectomy; Colorectal Neoplasms; Ede | 2002 |